Funding expands manufacturing readiness for Valley fever vaccine This follows Anivive’s $33MM NIAID contract for fungal vaccines In total, Anivive has secured over $80MM in contracts and preorders LONG BEACH, Calif., Jan. 27, 2025 /PRNewswire/ — Anivive Lifesciences, a software-driven…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.